FGF23 Regulates Renal Sodium Handling and Blood Pressure

Overview

Journal EMBO Mol Med

Specialty Molecular Biology

Date 2014 May 7

PMID 24797667

Citations 163

Authors

Olena Andrukhova

Svetlana Slavic

Alina Smorodchenko

Ute Zeitz

Victoria Shalhoub

Beate Lanske

Elena E Pohl

Reinhold G Erben

Affiliations

Soon will be listed here.

Abstract

Fibroblast growth factor-23 (FGF23) is a bone-derived hormone regulating renal phosphate reabsorption and vitamin D synthesis in renal proximal tubules. Here, we show that FGF23 directly regulates the membrane abundance of the Na(+):Cl(-) co-transporter NCC in distal renal tubules by a signaling mechanism involving the FGF receptor/αKlotho complex, extracellular signal-regulated kinase 1/2 (ERK1/2), serum/glucocorticoid-regulated kinase 1 (SGK1), and with-no lysine kinase-4 (WNK4). Renal sodium (Na(+)) reabsorption and distal tubular membrane expression of NCC are reduced in mouse models of Fgf23 and αKlotho deficiency. Conversely, gain of FGF23 function by injection of wild-type mice with recombinant FGF23 or by elevated circulating levels of endogenous Fgf23 in Hyp mice increases distal tubular Na(+) uptake and membrane abundance of NCC, leading to volume expansion, hypertension, and heart hypertrophy in a αKlotho and dietary Na(+)-dependent fashion. The NCC inhibitor chlorothiazide abrogates FGF23-induced volume expansion and heart hypertrophy. Our findings suggest that FGF23 is a key regulator of renal Na(+) reabsorption and plasma volume, and may explain the association of FGF23 with cardiovascular risk in chronic kidney disease patients.

Citing Articles

FGF-based drug discovery: advances and challenges.

Chen G, Chen L, Li X, Mohammadi M Nat Rev Drug Discov. 2025; .

PMID: 39875570 DOI: 10.1038/s41573-024-01125-w.

Decoding FGF/FGFR Signaling: Insights into Biological Functions and Disease Relevance.

Edirisinghe O, Ternier G, Alraawi Z, Kumar T Biomolecules. 2025; 14(12.

PMID: 39766329 PMC: 11726770. DOI: 10.3390/biom14121622.

Interrelationships among metabolic syndrome, bone-derived cytokines, and the most common metabolic syndrome-related diseases negatively affecting bone quality.

Martiniakova M, Mondockova V, Kovacova V, Babikova M, Zemanova N, Biro R Diabetol Metab Syndr. 2024; 16(1):217.

PMID: 39238022 PMC: 11378428. DOI: 10.1186/s13098-024-01440-7.

Fibroblast Growth Factors in Cardiovascular Disease.

Morita H, Hoshiga M J Atheroscler Thromb. 2024; 31(11):1496-1511.

PMID: 39168622 PMC: 11537794. DOI: 10.5551/jat.RV22025.

Evaluation of maternal serum fibroblast growth factor-23 levels in fetal growth restriction and gestational hypertensive disease.

Karacan E, Kilincdemir Turgut U, Buyukbayram H, Guney M Rev Assoc Med Bras (1992). 2024; 70(6):e20231496.

PMID: 39045952 PMC: 11288275. DOI: 10.1590/1806-9282.20231496.

References

Weber T, Liu S, Indridason O, Quarles L . Serum FGF23 levels in normal and disordered phosphorus homeostasis. J Bone Miner Res. 2003; 18(7):1227-34. DOI: 10.1359/jbmr.2003.18.7.1227. View

Barron W, Stamoutsos B, Lindheimer M . Role of volume in the regulation of vasopressin secretion during pregnancy in the rat. J Clin Invest. 1984; 73(4):923-32. PMC: 425103. DOI: 10.1172/JCI111316. View

Andrukhova O, Smorodchenko A, Egerbacher M, Streicher C, Zeitz U, Goetz R . FGF23 promotes renal calcium reabsorption through the TRPV5 channel. EMBO J. 2014; 33(3):229-46. PMC: 3983685. DOI: 10.1002/embj.201284188. View

Nehgme R, Fahey J, Smith C, Carpenter T . Cardiovascular abnormalities in patients with X-linked hypophosphatemia. J Clin Endocrinol Metab. 1997; 82(8):2450-4. DOI: 10.1210/jcem.82.8.4181. View

Dhingra R, Sullivan L, Fox C, Wang T, DAgostino Sr R, Gaziano J . Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med. 2007; 167(9):879-85. DOI: 10.1001/archinte.167.9.879. View

Saito H, Maeda A, Ohtomo S, Hirata M, Kusano K, Kato S . Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo. J Biol Chem. 2004; 280(4):2543-9. DOI: 10.1074/jbc.M408903200. View

May A, Puoti A, Gaeggeler H, Horisberger J, Rossier B . Early effect of aldosterone on the rate of synthesis of the epithelial sodium channel alpha subunit in A6 renal cells. J Am Soc Nephrol. 1997; 8(12):1813-22. DOI: 10.1681/ASN.V8121813. View

Ohta A, Rai T, Yui N, Chiga M, Yang S, Lin S . Targeted disruption of the Wnk4 gene decreases phosphorylation of Na-Cl cotransporter, increases Na excretion and lowers blood pressure. Hum Mol Genet. 2009; 18(20):3978-86. DOI: 10.1093/hmg/ddp344. View

Tsujikawa H, Kurotaki Y, Fujimori T, Fukuda K, Nabeshima Y . Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. Mol Endocrinol. 2003; 17(12):2393-403. DOI: 10.1210/me.2003-0048. View

10.

Li Y, Amling M, Pirro A, Priemel M, Meuse J, Baron R . Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology. 1998; 139(10):4391-6. DOI: 10.1210/endo.139.10.6262. View

11.

Juppner H, Wolf M, Salusky I . FGF-23: More than a regulator of renal phosphate handling?. J Bone Miner Res. 2010; 25(10):2091-7. PMC: 3153315. DOI: 10.1002/jbmr.170. View

12.

van der Lubbe N, Lim C, Meima M, Van Veghel R, Rosenbaek L, Mutig K . Aldosterone does not require angiotensin II to activate NCC through a WNK4-SPAK-dependent pathway. Pflugers Arch. 2012; 463(6):853-63. PMC: 3350624. DOI: 10.1007/s00424-012-1104-0. View

13.

Hesse M, Frohlich L, Zeitz U, Lanske B, Erben R . Ablation of vitamin D signaling rescues bone, mineral, and glucose homeostasis in Fgf-23 deficient mice. Matrix Biol. 2006; 26(2):75-84. DOI: 10.1016/j.matbio.2006.10.003. View

14.

Lang F, Artunc F, Vallon V . The physiological impact of the serum and glucocorticoid-inducible kinase SGK1. Curr Opin Nephrol Hypertens. 2009; 18(5):439-48. PMC: 2883450. DOI: 10.1097/MNH.0b013e32832f125e. View

15.

Anour R, Andrukhova O, Ritter E, Zeitz U, Erben R . Klotho lacks a vitamin D independent physiological role in glucose homeostasis, bone turnover, and steady-state PTH secretion in vivo. PLoS One. 2012; 7(2):e31376. PMC: 3272012. DOI: 10.1371/journal.pone.0031376. View

16.

Erben R, Soegiarto D, Weber K, Zeitz U, Lieberherr M, Gniadecki R . Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D. Mol Endocrinol. 2002; 16(7):1524-37. DOI: 10.1210/mend.16.7.0866. View

17.

Harootunian A, Kao J, Eckert B, Tsien R . Fluorescence ratio imaging of cytosolic free Na+ in individual fibroblasts and lymphocytes. J Biol Chem. 1989; 264(32):19458-67. View

18.

Pacheco-Alvarez D, Cristobal P, Meade P, Moreno E, Vazquez N, Munoz E . The Na+:Cl- cotransporter is activated and phosphorylated at the amino-terminal domain upon intracellular chloride depletion. J Biol Chem. 2006; 281(39):28755-63. DOI: 10.1074/jbc.M603773200. View

19.

Nesterov V, Dahlmann A, Krueger B, Bertog M, Loffing J, Korbmacher C . Aldosterone-dependent and -independent regulation of the epithelial sodium channel (ENaC) in mouse distal nephron. Am J Physiol Renal Physiol. 2012; 303(9):F1289-99. DOI: 10.1152/ajprenal.00247.2012. View

20.

WILSON F, Choate K, Ishikawa K, Desitter I, Gunel M, Milford D . Human hypertension caused by mutations in WNK kinases. Science. 2001; 293(5532):1107-12. DOI: 10.1126/science.1062844. View